We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
28 result(s) found, displaying 1 to 10
-
Sep-2025Prescription medicine evaluationActive ingredient: norucholic acid.
-
Designation or determinationOrphan drug
-
May-2025Prescription medicine evaluationActive ingredient: budesonide.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BUDENOFALK budesonide 4 mg suppository strip pack.
-
Cancellation by sponsorRequested by Dr Falk Pharma Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JORVEZA budesonide 0.5 mg orally disintegrating tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JORVEZA budesonide 1 mg orally disintegrating tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SALOFALK mesalazine 1g enteric coated tablet, blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for URSO ursodeoxycholic acid 500 mg tablet blister pack.